-+ 0.00%
-+ 0.00%
-+ 0.00%

RBC Capital Reinstates Outperform on Bio-Rad Laboratories, Announces $320 Price Target

Benzinga·05/15/2026 13:19:33
Listen to the news
RBC Capital analyst Dan Leonard reinstates Bio-Rad Laboratories (NYSE:BIO) with a Outperform and announces $320 price target.